Covered recipient · General Payments record
EMMANUEL MOMPI
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$8,823.73
- Reported across 238 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $701.46 | 32 |
| Gift | $81.81 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $334.08 | 19 |
| Novo Nordisk AS | $121.83 | 1 |
| Braintree Laboratories, Inc. | $103.86 | 2 |
| Celgene Corporation | $52.99 | 3 |
| RedHill Biopharma Inc. | $46.60 | 2 |
| Janssen Biotech, Inc. | $36.01 | 2 |
| GENZYME CORPORATION | $30.65 | 1 |
| Ardelyx, Inc. | $21.00 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.32 | 1 |
| PFIZER INC. | $17.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $64.36 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054654 | CMS |
| ABBVIE INC. | $4.40 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054656 | CMS |
| ABBVIE INC. | $30.19 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054658 | CMS |
| ABBVIE INC. | $11.21 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054660 | CMS |
| ABBVIE INC. | $4.95 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054662 | CMS |
| ABBVIE INC. | $2.43 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054664 | CMS |
| ABBVIE INC. | $33.98 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054666 | CMS |
| ABBVIE INC. | $2.94 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054668 | CMS |
| ABBVIE INC. | $34.57 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054670 | CMS |
| ABBVIE INC. | $6.44 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054672 | CMS |
| ABBVIE INC. | $22.52 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054674 | CMS |
| ABBVIE INC. | $6.21 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054676 | CMS |
| ABBVIE INC. | $24.12 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054678 | CMS |
| ABBVIE INC. | $6.55 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054680 | CMS |
| ABBVIE INC. | $6.02 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054682 | CMS |
| ABBVIE INC. | $6.33 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054684 | CMS |
| ABBVIE INC. | $31.80 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054686 | CMS |
| ABBVIE INC. | $23.40 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054688 | CMS |
| ABBVIE INC. | $11.66 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105054690 | CMS |
| Ardelyx, Inc. | $21.00 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146696292 | CMS |
| Braintree Laboratories, Inc. | $22.05 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125516447 | CMS |
| Braintree Laboratories, Inc. | $81.81 | 11/04/2024 | Gift | Undisputed | 01/23/2026 | 1125516449 | CMS |
| Celgene Corporation | $26.22 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101138382 | CMS |
| Celgene Corporation | $13.36 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101138384 | CMS |
| Celgene Corporation | $13.41 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101138410 | CMS |
| GENZYME CORPORATION | $30.65 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139715384 | CMS |
| Janssen Biotech, Inc. | $17.47 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078494213 | CMS |
| Janssen Biotech, Inc. | $18.54 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078493920 | CMS |
| Novo Nordisk Inc | $121.83 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097522609 | CMS |
| PFIZER INC. | $17.93 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131079838 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.32 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151098199 | CMS |
| RedHill Biopharma Inc. | $23.70 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095476793 | CMS |
| RedHill Biopharma Inc. | $22.90 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095476795 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.